Translate

Monday, June 21, 2010

Cadila Healthcare receives phase-I clinical trial permission from DCGI

Cadila Healthcare has received phase-I clinical trial permission from the DCGI for ZYOG1, a novel GLP-1 agonist, designed and developed at the company's research centre using a unique platform technology. ZYOG1 is a novel, oral anti-diabetic molecule.

No comments:

Economic Event Calendar

GMT+5:30 Event Vol. Actual Consensus Previous
Thursday, Jun 12
18:00 Producer Price Index (MoM) 2 0.1% 0.2% -0.2% Revised from -0.5%
20:00 EIA Natural Gas Storage Change 1 109B 108B 122B
21:00 4-Week Bill Auction 1 4.08% 4.17%
21:30 USDA WASDE Report 1
22:30 30-Year Bond Auction 1 4.844% 4.819%
Friday, Jun 13
04:00 Business NZ PMI 2 53.9
14:00 Consumer Inflation Expectations 2 3.4%
18:00 Manufacturing Sales (MoM) 1 -2.0% -1.4%
18:00 Capacity Utilization 1 79.8% 79.8%
18:00 Wholesale Sales (MoM) 1 -0.9% 0.2%
Economic Calendar >> Add to your site

Best Mutual Funds

Recent Posts

Search This Blog

IPO's Calendar

Market Screener

NSE BSE Tiker

Custom Pivot Calculator

Popular Posts

Market & MF Screener